Park Avenue Institutional Advisers LLC

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 4, 2026), Park Avenue Institutional Advisers LLC reported 2 stock positions worth $198.7 million. Its top holding was Janus Henderson Aa-A Clo ETF (JA) at 50.4% of the portfolio, followed by Janus Hdrsn Ass BKD Sec ETF (JABS, 49.6%). Compared with Q1 2026, it sold out of 3. The biggest sale was an exit from Revolution Medicines (RVMD).

Most Recent 13F
Q2 2026
Location
New York, NY
CIK
0001640801
Portfolio Value
$198.7M (Q2 2026)
SEC Filing
0001193125-26-331696 ↗ filed Aug 4, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $45.3M Q1 2024 Q2 2024: $67.2M Q2 2024 Q3 2024: $53.6M Q3 2024 Q4 2024: $14.0M Q4 2024 Q3 2025: $99.6M Q3 2025 Q4 2025: $1.0M Q4 2025 Q1 2026: $199.2M Q1 2026 Q2 2026: $198.7M $198.7M Q2 2026

Holdings 2 stocks · $198.7M
JA Janus Henderson Aa-A Clo ETF 50.38% 2,000,000 $100.1M No change
JABS Janus Hdrsn Ass BKD Sec ETF 49.62% 1,975,000 $98.6M No change

Portfolio Sells Q1 2026 → Q2 2026
RVMD Revolution Medicines Inc. Sold out 0.00% −0.25
BRZE Braze Inc. Class A Sold out 0.00% −0.11
TTAN Servicetitan Inc. Class A Sold out 0.00% −0.09

Portfolio Buys Q1 2026 → Q2 2026
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 2$198.7MJA, JABS
Q1 2026 5$199.2MJA, JABS, RVMD, BRZE, TTAN
Q4 2025 3$1.0MRVMD, BRZE, TTAN
Q3 2025 1$99.6MJABS
Q4 2024 3$14.0MMBB, BKLN, SRLN
Q3 2024 5$53.6MMBB, VMBS, JNK, HYG, SRLN
Q2 2024 5$67.2MMBB, VMBS, BKLN, SRLN, JNK
Q1 2024 5$45.3MMBB, VMBS, BKLN, SRLN, COIN